Study to Evaluate the Safety and Efficacy of Formoterol in a Daily Dose of 18 µg (9 µg Twice Daily) in Japanese Chronic Obstructive Pulmonary Disease (COPD) Patients
Clinical trial NCT01047553 · COMPLETED
Trial details
- NCT number
- NCT01047553
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 251
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.